| Drug Name |
Flutamide |
| Drug ID |
BADD_D00943 |
| Description |
An antiandrogen with about the same potency as cyproterone in rodent and canine species. |
| Indications and Usage |
For the management of locally confined Stage B2-C and Stage D2 metastatic carcinoma of the prostate |
| Marketing Status |
approved; investigational |
| ATC Code |
L02BB01 |
| DrugBank ID |
DB00499
|
| KEGG ID |
D00586
|
| MeSH ID |
D005485
|
| PubChem ID |
3397
|
| TTD Drug ID |
D0Y0SW
|
| NDC Product Code |
69097-915; 80725-600; 44657-0048; 60429-272; 12780-4750; 44657-0056; 49884-753; 53104-7536 |
| UNII |
76W6J0943E
|
| Synonyms |
Flutamide | Niftolid | Niftolide | Chimax | Cytamid | Eulexin | Euflex | Drogenil | Eulexine | Fluken | Flulem | Flumid | Fluta 1A Pharma | Fluta-cell | Fluta cell | Flutacell | Fluta-GRY | Fluta GRY | FlutaGRY | Flutamin | Flutandrona | Flutaplex | Flutexin | Fugerel | Grisetin | Novo-Flutamide | Novo Flutamide | NovoFlutamide | Oncosal | PMS-Flutamide | PMS Flutamide | Prostacur | Prostica | Prostogenat | SCH-13521 | SCH 13521 | SCH13521 | Testotard | Apimid | Apo-Flutamide | Apo Flutamide | ApoFlutamide |
